The legacy of Viagra and its influence on the healthcare landscape presents a thorny question for shareholders . Initially a blockbuster drug, competitors have significantly chipped away at its market presence , creating challenges for companies escort connected to the original patent holder and similar formulas. While some companies might gain fro